论文部分内容阅读
2015年2月26日,美国免疫实施咨询委员会(The Advisory Committee on Immunization Practices,ACIP)建议:接种1剂黄热病疫苗(Yellow Fever Vaccine,YFV)可提供持久保护,适用于大多数旅行者。美国ACIP同时建议具有暴露风险的实验室人员和特定旅行者应接种加强剂次YFV。美国ACIP的流行性乙型脑炎和黄热病疫苗工作组评估了已发表和未发表的关于YFV的免疫原性和安全性资料,利
On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) recommended that a Yellow Fever Vaccine (YFV) is administered for long-term protection and is suitable for most travelers. ACIP also recommends that laboratory personnel with exposure risk and certain travelers should be vaccinated with enhancer agent YFV. The United States ACIP Working Group on JE and Yellow Fever Vaccines evaluated published and unpublished data on the immunogenicity and safety of YFV,